MOLLYANN PERRY: Open Payments
NPI 1083202592 · MESA, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$595 in 6 payments from 5 companies in 2025. Trend: 2023 $469 · 2024 $451 · 2025 $595
Food & beverage: $595
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $124 |
| Exact Sciences Corporation | 2 | $123 |
| Teva Pharmaceuticals USA, Inc. | 1 | $122 |
| Otsuka America Pharmaceutical, Inc. | 1 | $122 |
| Gilead Sciences, Inc. | 1 | $104 |
Products named: CAPLYTA, UZEDY, REXULTI, The Cologuard Plus Collection Kit, Cologuard Collection Kit.
Industry payments across AZ — which companies pay providers there.
